I'm a little confused on this announcement if someone could clarify.
Are we still awaiting initial dosing efficacy results post the safety results released from all patients due now Q4 ? this after the self reported improvement announced of one patient?,
or do we need to wait now for the efficacy of MAD at end of the year 2025 ?
thanks
Ann: Commencement of RP11 Multiple Dose Trial, page-4
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $863.2M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.5¢ | $165.9K | 879.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 74706 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 201871 | 8 |
View Market Depth
| Last trade - 14.14pm 04/11/2024 (20 minute delay) ? |
| PYC (ASX) Chart |